Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis.

Added 383 days ago (11.11.2020)
Authors: Paolacci S, Ceccarini MR, Codini M, Manara E, Tezzele S, Percio M, Capodicasa N, Kroni D, Dundar M, Ergoren MC, Sanlidag T, Beccari T, Farronato M, Farronato G, Tartaglia GM, Bertelli M
PubMed id: 33170175
Read article